Cargando…
Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
There is growing evidence that increased levels of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) may contribute to endothelial dysfunction. Studies in animal models as well as in humans have suggested that the increase in ADMA occurs at a time when vascular disease has not...
Autores principales: | Franceschelli, Sara, Ferrone, Alessio, Pesce, Mirko, Riccioni, Graziano, Speranza, Lorenza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876119/ https://www.ncbi.nlm.nih.gov/pubmed/24351825 http://dx.doi.org/10.3390/ijms141224412 |
Ejemplares similares
-
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017) -
The Biological Effects of Ivabradine in Cardiovascular Disease
por: Speranza, Lorenza, et al.
Publicado: (2012) -
The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010) -
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018) -
Licocalchone-C Extracted from Glycyrrhiza Glabra Inhibits Lipopolysaccharide-Interferon-γ Inflammation by Improving Antioxidant Conditions and Regulating Inducible Nitric Oxide Synthase Expression
por: Franceschelli, Sara, et al.
Publicado: (2011)